Effects of iron and copper overload on the human liver: An ultrastructural study

Current Medicinal Chemistry

Volumn 21, Issue 33, 2015, Pages 3768-3774

  Fanni, D ^a   Fanos, V ^a   Gerosa, C ^a   Piras, M ^a   Dessi A ^a   Atzei, A ^a   Van, Eyken P ^b   Gibo, Y ^c   Faa, G ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b DEPARTMENT OF CARDIOLOGY   (Belgium)

^c Hepatology Clinic   (Japan)

Author keywords

Beta thalassemia; Copper overload; Iron overload; Liver; Transmission electron microscopy; Wilson's disease.

Indexed keywords

COPPER; FAT DROPLET; HEMOSIDERIN; IRON; SIDEROPHORE;

ADULT; APOPTOSIS; ARTICLE; BETA THALASSEMIA; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER OVERLOAD; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; INTOXICATION; IRON OVERLOAD; KUPFFER CELL; LIVER; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; LYSOSOME; MALE; SMOOTH ENDOPLASMIC RETICULUM; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; WILSON DISEASE; METABOLISM; NEEDLE BIOPSY; PATHOLOGY;

BETA-THALASSEMIA; BIOPSY, NEEDLE; COPPER; HEPATOLENTICULAR DEGENERATION; HUMANS; IRON; LIVER;

EID: 84930225531     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867321666140601163244     Document Type: Article

References (28)

1. Shaw GC, Cope JJ, Li L, Corson K, Hersey C, Ackermann GE, et al. Mitoferrin is essential for erythroid iron assimilation. Nature. 2006, 440(7080): 96-100.
2. Crichton RR, Boelaert JR. Inorganic biochemistry of iron metabolism: from molecular mechanisms to clinical consequences: John Wiley & Sons; 2001.
3. Faa G, Crisponi G. Iron chelating agents in clinical practice. Coord. Chem. Rev., 1999, 184(1): 291-310.
4. Crichton RR. Biological Inorganic Chemistry: A New Introduction to Molecular Structure and Function: Elsevier; 2012.
5. Letelier ME, Sanchez-Jofre S, Peredo-Silva L, Cortes-Troncoso J, Aracena-Parks P. Mechanisms underlying iron and copper ions toxicity in biological systems: Pro-oxidant activity and protein-binding effects. Chem. Biol. Interact., 2010, 188(1): 220-7.
6. Legssyer R, Geisser P, McArdle H, Crichton RR, Ward RJ. Comparison of injectable iron complexes in their ability to iron load tissues and to induce oxidative stress. Biometals: an international journal on the role of metal ions in biology, biochemistry, and medicine. 2003, 16(3): 425-33.
7. Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol. Appl. Pharmacol., 2005, 202(2): 199-211.
8. Zaccone V, Gasbarrini G. [From iron accumulation to organ damage]. Minerva medica. 2012, 103(2): 123-40.
9. Fargion S, Valenti L, Fracanzani AL. Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases. Dig. Liver. Dis.: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2011, 43(2): 89-95.
10. Mariani R, Trombini P, Pozzi M, Piperno A. Iron metabolism in thalassemia and sickle cell disease. Mediterr. J. Hematol. Infect. Dis. 2009, 1(1): e2009006.
11. Mancosu MG, Galanello R, Ambu R, De Virgiliis S, Giagu N, Cao A, et al. [Histological picture of liver disease in thalassemia intermedia]. Pathologica. 2000, 92(4): 241-8.
12. Faa G, Terlizzo M, Gerosa C, Congiu T, Angelucci E. Patterns of iron distribution in liver cells in beta-thalassemia studied by X-ray microanalysis. Haematologica. 2002, 87(5): 479-84.
13. Lee J, Prohaska JR, Thiele DJ. Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Proc. Natl. Acad. Sci. U S A., 2001, 98(12): 6842-6847.
14. Seymour CA. Copper toxicity in man. McC Howell JG, J.M., editor. Florida: CRC Press, Boca Raton; 1987.
15. Kozlowski H, Kolkowska P, Watly J, Krzywoszynska K, Potocki S. General aspects of metal toxicity. Current Pharmacol Design. 2013:in press.
16. Manzl C, Enrich J, Ebner H, Dallinger R, Krumschnabel G. Copper-induced formation of reactive oxygen species causes cell death and disruption of calcium homeostasis in trout hepatocytes. Toxicology. 2004, 196(1-2): 57-64.
17. Farinati F, Cardin R, D'Inca R, Naccarato R, Sturniolo GC. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease. J. Lab. Clin. Med., 2003, 141(6): 372-377.
18. Faa G, Nurchi V, Demelia L, Ambu R, Parodo G, Congiu T, et al. Uneven hepatic copper distribution in Wilson's disease. J. Hepatol. 1995, 22(3): 303-8.
19. Iancu TC. Iron and neoplasia: ferritin and hemosiderin in tumor cells. Ultrastructural pathology. 1989, 13(5-6): 573-84.
20. Durackova Z. Some current insights into oxidative stress. Physiological research / Academia Scientiarum Bohemoslovaca. 2010, 59(4): 459-69.
21. Uriu-Adams JY, Keen CL. Copper, oxidative stress, and human health. Mol. Aspects. Med., 2005, 26(4-5): 268-298.
22. Brewer GJ. Risks of copper and iron toxicity during aging in humans. Chem. Res. Toxicol., 2010, 23(2): 319-326.
23. St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem., 2002, 277(47): 44784-90.
24. Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, et al. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J. Neurol. Sci., 2005, 233(1): 145-162.
25. Langley A, Dameron CT. Copper and anesthesia: clinical relevance and management of copper related disorders. Anesthesiol. Res. Pract., 2013, 2013: 750901.
26. Burkitt MJ. Chemical, biological and medical controversies surrounding the fenton reaction. Progress in Reaction Kinetics and Mechanism. 2003, 28(1): 75-103.
27. Cheng Z, Li Y. What Is Responsible for the Initiating Chemistry of Iron-Mediated Lipid Peroxidation: An Update. Chem. Rev., 2007, 107(3): 748-766.
28. Kuka S, Tatarkova Z, Kaplan P. Oxidative Damage to Proteins and Lipids During Ageing. Acta Medica Martiniana2012. p. 5.